General Biophysics
Our Research Initiatives
Neurodegeneration
Explore our approach to Alzheimer's disease.
Approximately 30 million people have Alzheimer’s Disease (AD). Unfortunately, there is no cure. We are developing a therapeutic approach to target microglial dysregulation. Our drug-device combination product is based on the proprietary xenon gas mixture delivered to patients through the automatic inhalation system.
Cellular Preservation Technology (CPT)
Discover our advancements in cell preservation.
We are developing innovative solutions to improve the availability of precious biological agents with potent therapeutic applications. Our initial product is a revolutionary platelet storage system which transforms the useful lifespan of platelets from five to fourteen days.